文献速递头颈甲状腺与浅表US

基于多模态超声与临床特征的列线图预测单灶甲状腺乳头状癌中央区淋巴结转移

A nomogram based on multimodal ultrasound and clinical features for the prediction of central lymph node metastasis in unifocal papillary thyroid carcinoma.
PubMed 文献 · Br J Radiol · 2024-01-01

本回顾性研究纳入390例单灶甲状腺乳头状癌患者,按2022年6月为界分为训练队列300例和验证队列90例,构建结合临床特征与多模态超声的列线图模型。多模态超声联合临床模型在训练队列AUC为0.80、验证队列AUC为0.77,优于其他模型,验证队列敏感度81.2%高于超声诊断的21.6%。

要点

  • 多模态超声联合临床特征列线图预测中央区淋巴结转移训练队列AUC 0.80、验证队列AUC 0.77。
  • 验证队列中联合模型敏感度81.2%,高于超声诊断的21.6%(P < .001)。
  • 联合模型特异度62.3%,与单纯临床模型47.2%相比无显著差异(P = .06)。

核心结论

  • 结合多模态超声与临床特征的无创列线图可作为术前预测单灶甲状腺乳头状癌中央区淋巴结转移的可靠工具。

研究设计与样本

  • 回顾性研究,纳入2017年1月至2022年10月接受多模态超声检查的390例单灶甲状腺乳头状癌患者,以2022年6月为截止日期分为训练队列300例和验证队列90例。

关键影像表现/征象

  • 训练队列中微钙化、虚拟触诊成像评分、虚拟触诊组织成像与定量最大值与中央区淋巴结转移显著相关(均P < .05)。
  • 临床因素年龄、直径与训练队列中央区淋巴结转移显著相关(均P < .05)。

诊断标准与关键数值

  • 多模态超声联合临床模型训练队列AUC为0.80,验证队列AUC为0.77。
  • 联合模型AUC优于其他模型:训练队列0.80 vs 0.72,验证队列0.77 vs 0.65(P < .01)。
  • 验证队列联合模型敏感度81.2%,超声诊断敏感度21.6%(P < .001)。
  • 验证队列联合模型特异度62.3%,单纯临床模型特异度47.2%(P = .06)。

临床应用与阅片要点

  • 作者认为结合多模态超声与临床特征的列线图可作为术前预测单灶甲状腺乳头状癌中央区淋巴结转移的可靠工具,有助于术前临床管理与诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To build a predictive model for central lymph node metastasis (CLNM) in unifocal papillary thyroid carcinoma (UPTC) using a combination of clinical features and multimodal ultrasound (MUS).

METHODS: This retrospective study, included 390 UPTC patients who underwent MUS between January 2017 and October 2022 and were divided into a training cohort (n = 300) and a validation cohort (n = 90) based on a cut-off date of June 2022. Independent indicators for constructing the predictive nomogram models were identified using multivariate regression analysis. The diagnostic yield of the 3 predictive models was also assessed using the area under the receiver operating characteristic curve (AUC).

RESULTS: Both clinical factors (age, diameter) and MUS findings (microcalcification, virtual touch imaging score, maximal value of virtual touch tissue imaging and quantification) were significantly associated with the presence of CLNM in the training cohort (all P < .05). A predictive model (MUS + Clin), incorporating both clinical and MUS characteristics, demonstrated favourable diagnostic accuracy in both the training cohort (AUC = 0.80) and the validation cohort (AUC = 0.77). The MUS + Clin model exhibited superior predictive performance in terms of AUCs over the other models (training cohort 0.80 vs 0.72, validation cohort 0.77 vs 0.65, P < .01). In the validation cohort, the MUS + Clin model exhibited higher sensitivity compared to the CLNM model for ultrasound diagnosis (81.2% vs 21.6%, P < .001), while maintaining comparable specificity to the Clin model alone (62.3% vs 47.2%, P = .06). The MUS + Clin model demonstrated good calibration and clinical utility across both cohorts.

CONCLUSION: Our nomogram combining non-invasive features, including MUS and clinical characteristics, could be a reliable preoperative tool to predict CLNM treatment of UPTC.

ADVANCES IN KNOWLEDGE: Our study established a nomogram based on MUS and clinical features for predicting CLNM in UPTC, facilitating informed preoperative clinical management and diagnosis.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang X, Dong X, Ma C, et al. A nomogram based on multimodal ultrasound and clinical features for the prediction of central lymph node metastasis in unifocal papillary thyroid carcinoma. Br J Radiol. 2024. PMID: 38263832. doi:10.1093/bjr/tqad006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。